Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Bates

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Kidney International Reports|September 14, 2019
Acute Kidney Injury Following Eastern Russell's Viper (<i>Daboia siamensis</i>) Snakebite in MyanmarSam Alfred, David Bates, Julian White, et al.
BMJ Open|July 14, 2016
Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort studyHisham Aljadhey, Mansour A Mahmoud, Yusuf Ahmed, et al.
Toxicon: X|August 25, 2020
Twelve month prospective study of snakebite in a major teaching hospital in Mandalay, Myanmar; Myanmar Snakebite Project (MSP)Julian White, Sam Alfred, David Bates, et al.
Molecular Cell|April 6, 2019
Gamblers: An Antibiotic-Induced Evolvable Cell Subpopulation Differentiated by Reactive-Oxygen-Induced General Stress ResponseJohn P Pribis, Libertad García-Villada, Yin Zhai, et al.
The Lancet. Neurology|April 17, 2007
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoringLudwig Kappos, David Bates, Hans-Peter Hartung, et al.
Science Advances|January 17, 2017
Holliday junction trap shows how cells use recombination and a junction-guardian role of RecQ helicaseJun Xia, Li-Tzu Chen, Qian Mei, et al.
Elife|October 31, 2013
Engineered proteins detect spontaneous DNA breakage in human and bacterial cellsChandan Shee, Ben D Cox, Franklin Gu, et al.
Nature|February 19, 2025
Endogenous DNA damage at sites of terminated transcriptsJingjing Liu, Jullian O Perren, Cody M Rogers, et al.
Frontiers in Public Health|October 12, 2023
The promise of digital healthcare technologiesAndy Wai Kan Yeung, Ali Torkamani, Atul J Butte, et al.
The Lancet. Neurology|July 23, 2011
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoringLudwig Kappos, David Bates, Gilles Edan, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Kidney International Reports|September 14, 2019
Acute Kidney Injury Following Eastern Russell's Viper (<i>Daboia siamensis</i>) Snakebite in MyanmarSam Alfred, David Bates, Julian White, et al.
BMJ Open|July 14, 2016
Incidence of adverse drug events in public and private hospitals in Riyadh, Saudi Arabia: the (ADESA) prospective cohort studyHisham Aljadhey, Mansour A Mahmoud, Yusuf Ahmed, et al.
Toxicon: X|August 25, 2020
Twelve month prospective study of snakebite in a major teaching hospital in Mandalay, Myanmar; Myanmar Snakebite Project (MSP)Julian White, Sam Alfred, David Bates, et al.
Molecular Cell|April 6, 2019
Gamblers: An Antibiotic-Induced Evolvable Cell Subpopulation Differentiated by Reactive-Oxygen-Induced General Stress ResponseJohn P Pribis, Libertad García-Villada, Yin Zhai, et al.
The Lancet. Neurology|April 17, 2007
Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoringLudwig Kappos, David Bates, Hans-Peter Hartung, et al.
Science Advances|January 17, 2017
Holliday junction trap shows how cells use recombination and a junction-guardian role of RecQ helicaseJun Xia, Li-Tzu Chen, Qian Mei, et al.
Elife|October 31, 2013
Engineered proteins detect spontaneous DNA breakage in human and bacterial cellsChandan Shee, Ben D Cox, Franklin Gu, et al.
Nature|February 19, 2025
Endogenous DNA damage at sites of terminated transcriptsJingjing Liu, Jullian O Perren, Cody M Rogers, et al.
Frontiers in Public Health|October 12, 2023
The promise of digital healthcare technologiesAndy Wai Kan Yeung, Ali Torkamani, Atul J Butte, et al.
The Lancet. Neurology|July 23, 2011
Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoringLudwig Kappos, David Bates, Gilles Edan, et al.
Pageof 14